ECM
ALT icon

ExodusPoint Capital Management’s Altimmune ALT Stock Holding History

ExodusPoint Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$150K Buy
48,619
+36,698
+308% +$156K ﹤0.01% 1408
2025
Q4 		$43K Sell
11,921
-166,256
-93% -$725K ﹤0.01% 1457
2025
Q3 		$672K Buy
178,177
+138,918
+354% +$536K 0.01% 1095
2025
Q2 		$152K Sell
39,259
-1,668
-4% -$9.03K ﹤0.01% 1336
2025
Q1 		$205K Buy
+40,927
New +$259K ﹤0.01% 1294
2024
Q4 		– Sell
-45,769
Closed -$281K – 1475
2024
Q3 		$281K Buy
45,769
+28,259
+161% +$191K ﹤0.01% 1381
2024
Q2 		$116K Sell
17,510
-63,403
-78% -$468K ﹤0.01% 1419
2024
Q1 		$824K Buy
+80,913
New +$823K 0.01% 1004
2022
Q3 		– Sell
-305,879
Closed -$3.58M – 1847
2022
Q2 		$3.58M Buy
305,879
+279,528
+1,061% +$1.72M 0.04% 528
2022
Q1 		$160K Buy
+26,351
New +$194K ﹤0.01% 1948
2021
Q4 		– Sell
-74,358
Closed -$841K – 2128
2021
Q3 		$841K Buy
74,358
+62,717
+539% +$763K 0.01% 1109
2021
Q2 		$115K Sell
11,641
-65,007
-85% -$889K ﹤0.01% 2123
2021
Q1 		$1.08M Buy
76,648
+59,435
+345% +$961K 0.02% 871
2020
Q4 		$194K Buy
+17,213
New +$203K ﹤0.01% 1740
2020
Q3 		– Sell
-23,400
Closed -$251K – 1708
2020
Q2 		$251K Buy
+23,400
New +$129K 0.01% 1407

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ExodusPoint Capital Management's ALT Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Altimmune (ALT) stake by 308% in Q1 2026, buying an estimated $156K and bringing the position to 48,619 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1408.

ExodusPoint Capital Management first reported a position in ALT in Q2 2020 and has held it in 15 quarters since. The position peaked at $3.58M in Q2 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • ExodusPoint Capital Management held 48,619 shares of Altimmune worth $150K as of Q1 2026.
  • ExodusPoint Capital Management bought 36,698 Altimmune shares in Q1 2026, an estimated $156K.
  • Altimmune made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1408 holding.
  • ExodusPoint Capital Management first reported a position in Altimmune in Q2 2020 and has held it in 15 quarters since.
  • ExodusPoint Capital Management's Altimmune position peaked at $3.58M in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.